We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

100 hedge funds and large institutions have $486M invested in Lumos Pharma, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 27 increasing their positions, 32 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more capital invested

Capital invested by funds: $296M → $486M (+$190M)

60% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 15

27% more call options, than puts

Call options by funds: $59.5M | Put options by funds: $47M

9% more funds holding

Funds holding: 92 → 100 (+8)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

16% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 32

Holders
100
Holders Change
+8
Holders Change %
+8.7%
% of All Funds
2.67%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
27
Reduced
32
Closed
15
Calls
$59.5M
Puts
$47M
Net Calls
+$12.5M
Net Calls Change
-$1.85M

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$5.24M
2
First Eagle Investment Management
First Eagle Investment Management
New York
+$4.92M
3
BFA
BlackRock Fund Advisors
California
+$2.56M
4
Wells Fargo
Wells Fargo
California
+$2.51M
5
Barclays
Barclays
United Kingdom
+$2.29M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$37.9M
2
PC
PointState Capital
New York
-$20.6M
3
HT
HAP Trading
New York
-$6.16M
4
Stifel Financial
Stifel Financial
Missouri
-$4.1M
5
DFO
Duquesne Family Office
New York
-$3.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$2.81M -$133K -447 -5%
Principal Financial Group
27
Principal Financial Group
Iowa
$2.38M -$99.1K -333 -5%
Group One Trading
28
Group One Trading
Illinois
$2.27M +$837K +2,812 +79%
BIM
29
BlackRock Investment Management
Delaware
$2.27M -$21.1K -71 -1%
Charles Schwab
30
Charles Schwab
California
$2.16M +$336K +1,128 +23%
TCM
31
Tygh Capital Management
Oregon
$1.63M +$1.35M +4,541 New
Invesco
32
Invesco
Georgia
$1.47M +$1.22M +4,108 New
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$1.46M +$5.36K +18 +0.4%
AllianceBernstein
34
AllianceBernstein
Tennessee
$1.32M – – –
PCM
35
Price Capital Management
Louisiana
$1.27M +$1.05M +3,543 New
RCM
36
RA Capital Management
Massachusetts
$1.19M – – –
AWCI
37
Alpine Woods Capital Investors
New York
$1.19M +$992K +3,333 New
TA
38
Teachers Advisors
New York
$1.1M – – –
SGAM
39
Smith Group Asset Management
Texas
$1.09M +$910K +3,056 New
Two Sigma Advisers
40
Two Sigma Advisers
New York
$1.07M +$890K +2,989 New
BSW
41
Buckingham Strategic Wealth
Missouri
$1.05M – – –
AQR Capital Management
42
AQR Capital Management
Connecticut
$1.02M -$123K -412 -13%
SFM
43
Sphera Funds Management
Israel
$994K +$827K +2,778 New
Citadel Advisors
44
Citadel Advisors
Florida
$923K +$614K +2,063 +398%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$916K +$751K +2,522 New
ProShare Advisors
46
ProShare Advisors
Maryland
$905K +$17.3K +58 +2%
HT
47
HAP Trading
New York
$878K -$6.16M -20,705 -89%
ZIM
48
Zacks Investment Management
Illinois
$878K -$242K -812 -25%
State Board of Administration of Florida Retirement System
49
State Board of Administration of Florida Retirement System
Florida
$876K -$32.7K -110 -4%
Swiss National Bank
50
Swiss National Bank
Switzerland
$859K – – –
1
2
3 4 5

LUMO Hedge Fund Activity: Q4 2014 in Review

100 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q4 2014, worth a combined $486M — up 64% from $296M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new LUMO positions and 15 closed out — a net gain of 9 holders — while 27 added to existing stakes and 32 trimmed.

The largest buyer was BlackRock Institutional Trust, adding an estimated $5.24M. The largest seller was Fidelity Investments, cutting an estimated $37.9M.

  • 100 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q4 2014, up from 92 in Q3 2014.
  • Funds reported $486M of Lumos Pharma, Inc. Common Stock stock for Q4 2014, up 64% quarter-over-quarter.
  • 24 funds opened new Lumos Pharma, Inc. Common Stock positions in Q4 2014 and 15 closed out, a net change of +9 holders.
  • The largest Lumos Pharma, Inc. Common Stock buyer in Q4 2014 was BlackRock Institutional Trust, an estimated $5.24M added.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q4 2014 was Fidelity Investments, an estimated $37.9M sold.

Based on aggregated 13F filings for Q4 2014.